BTIG cuts Bright Minds Biosciences target price to $37 from $147
DRUG•BTIG cut its target price for Bright Minds Biosciences to $37 from $147.
Related News
Shell agrees sale of North West Shelf stake for $1.45 billion
SHEL•
Asian stocks retreat ahead of US midterms, oil steadies
SPY•
BofA Global Research raises Ares Management price objective to $164 from $156
ARES•
Xcel Energy: HSBC raises target price to $96.5 from $89
XEL•
Jazz Pharmaceuticals target price raised to $305 from $296 by RBC
JAZZ•